Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
The Clinical Journal of Pain
|
February 12, 1998
Do patient and physician expectations predict response to pain-relieving procedures?
B S Galer, L Schwartz, J A Turner
Journal of Pain and Symptom Management
|
July 1, 1995
Case reports and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (Complex Regional Pain Syndrome-1)
B S Galer, S Butler, M P Jensen
Pain
|
August 1, 1995
Chronic use of symptomatic headache medications
Michael Von Korff, Bradley S Galer, Paul Stang
The Clinical Journal of Pain
|
April 16, 1998
IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain
B S Galer, S Bruehl, R N Harden
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 29, 2002
Pharmacokinetics and safety of continuously applied lidocaine patches 5%
Arnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
Journal of Clinical Pharmacology
|
March 6, 2003
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature
Arnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
The New England Journal of Medicine
|
August 6, 2000
Herpes zoster
R H Dworkin, B S Galer, M C Rowbotham
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
July 2, 2013
Pathophysiology of sleep-dependent memory consolidation processes in children
C Urbain, S Galer, P Van Bogaert, et al.
Neurology
|
June 1, 1993
Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury
B S Galer, K V Miller, M C Rowbotham
Clinical Therapeutics
|
June 6, 2006
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee
Alan Kivitz, Carl Ma, Harry Ahdieh, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
The Clinical Journal of Pain
|
February 12, 1998
Do patient and physician expectations predict response to pain-relieving procedures?
B S Galer, L Schwartz, J A Turner
Journal of Pain and Symptom Management
|
July 1, 1995
Case reports and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (Complex Regional Pain Syndrome-1)
B S Galer, S Butler, M P Jensen
Pain
|
August 1, 1995
Chronic use of symptomatic headache medications
Michael Von Korff, Bradley S Galer, Paul Stang
The Clinical Journal of Pain
|
April 16, 1998
IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain
B S Galer, S Bruehl, R N Harden
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 29, 2002
Pharmacokinetics and safety of continuously applied lidocaine patches 5%
Arnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
Journal of Clinical Pharmacology
|
March 6, 2003
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature
Arnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
The New England Journal of Medicine
|
August 6, 2000
Herpes zoster
R H Dworkin, B S Galer, M C Rowbotham
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
July 2, 2013
Pathophysiology of sleep-dependent memory consolidation processes in children
C Urbain, S Galer, P Van Bogaert, et al.
Neurology
|
June 1, 1993
Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury
B S Galer, K V Miller, M C Rowbotham
Clinical Therapeutics
|
June 6, 2006
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee
Alan Kivitz, Carl Ma, Harry Ahdieh, et al.
Page
of 13